ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADHFE1 | Alcohol dehydrogenase, iron containing, 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BCO2 | Beta-carotene oxygenase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDH19 | Cadherin 19, type 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CFAP61 | Cilia and flagella associated protein 61 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CH507-396I9.6 | | Predicted membrane proteins
| | | | | Tissue enhanced |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COLQ | Collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRIP3 | Cysteine-rich protein 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSDC2 | Cold shock domain containing C2, RNA binding | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CTC-429P9.4 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000472547} | Predicted intracellular proteins
| | | | | Tissue enhanced |
CTNNA3 | Catenin (cadherin-associated protein), alpha 3 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DOK7 | Docking protein 7 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DPF3 | D4, zinc and double PHD fingers, family 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DTNA | Dystrobrevin, alpha | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ENAM | Enamelin | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ESRRB | Estrogen-related receptor beta | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FGF12 | Fibroblast growth factor 12 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FHOD3 | Formin homology 2 domain containing 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FILIP1 | Filamin A interacting protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
FRMD3 | FERM domain containing 3 | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GHRH | Growth hormone releasing hormone | Predicted secreted proteins
| | | | | Tissue enhanced |
GJA3 | Gap junction protein, alpha 3, 46kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLP1R | Glucagon-like peptide 1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GPR22 | G protein-coupled receptor 22 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRIP2 | Glutamate receptor interacting protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GSG1L | GSG1-like | Predicted membrane proteins
| | | | | Tissue enhanced |
HCN4 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
HSPB2 | Heat shock 27kDa protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
HSPB7 | Heat shock 27kDa protein family, member 7 (cardiovascular) | Predicted intracellular proteins
| | | | | Tissue enhanced |
IGSF5 | Immunoglobulin superfamily, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
IRX6 | Iroquois homeobox 6 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |